X

A new era in genomics

Andrew Powaleny   |     April 26, 2017   |   SHARE THIS

Personalized medicine has taken on a new meaning with the mapping of the human genome.

With a clearer understanding of each individual’s own genetic makeup, America’s Biopharmaceutical Companies are making groundbreaking innovations that deliver personalized medicines to patients. Personalized medicine is changing the course of treatment in a host of therapeutic areas – from oncology to cystic fibrosis; and holds incredible promise for diseases like Alzheimer’s. The completion of the Human Genome Project has catalyzed a new era of medicine, where scientific advances once unthinkable are today becoming a reality.

As part of the GOBOLDLY campaign, PhRMA is continuing our national dialogue series by discussing what genomics means in The New Era of Medicine with “Sequencing the Genome: Examining Modern Medicine” today, April 26th in partnership with The Atlantic. Over 40 percent of new medicines in development have the potential to be personalized medicines, and this event takes a deep dive into advances in genomic research and innovation, opportunities and challenges and what the future holds.

The program will be streamed live from 8:30 - 10:45 am ET, and those interested can join the conversation on Twitter with @PhRMA and #GoBoldy.

To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit www.innovation.org.  

Andrew Powaleny

Andrew Powaleny Andrew Powaleny is Director of Public Affairs at PhRMA. Before joining PhRMA in 2015, he worked at the House Energy and Commerce Committee and later as a communications consultant. Andrew came to Washington, D.C. via Connecticut and proudly runs with the DC Front Runners and serves as its co-race director. He is also a member of the National Lesbian Gay Journalists Association and a proud alum of The Fund for American Studies. He’s passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.

Topics: Research and Development, New Era of Medicine, GoBoldly

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates